Evaluation of parameters of the small airways and their changes under treatment with ciclesonide (320 mcg once daily) versus placebo in patients with asthma
Phase of Trial: Phase III
Latest Information Update: 06 Dec 2016
At a glance
- Drugs Ciclesonide (Primary)
- Indications Asthma
- Focus Pharmacodynamics
- 04 May 2012 Company (Takeda Global Research and Development Center) added to the associations field as reported by ClinicalTrials.gov record.
- 20 May 2007 Results have been reported.
- 19 Dec 2006 Status change